Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

How Sculptra Can Help You Say Goodbye To #OzempicFace For Good

Photo Credit: Shutterstock

Semaglutide, also known as Ozempic, Wegovy, or Rybelsus, has become one of the hottest topics in the healthcare world today. Originally designed as an anti-diabetic medication that is injected once a week for the treatment of type 2 diabetes to assist with the control of blood sugar levels and lower the risk of heart disease, it has now become one of the most commonly used weight-loss drugs.

In June 2021, the FDA announced the approval of Semaglutide for weight loss in obesity treatment (BMI >30), and the treatment of overweight patients that have associated high-risk medical conditions such as heart disease. Just 11 months later, Kim Kardashian stunned the world at the Met Gala with her slim waist, facial appearance, and resemblant shape of Marilyn Monroe, revealing Semaglutide as the secret behind her weight loss and sparking the Ozempic craze.

The hashtag “#OzempicFace” began trending on social media, with individuals sharing the not-so-fetching aftermath of Semaglutide, including facial sagging, aging, changes in color, and overall gauntness. Actual patients began releasing photos and videos of their first-hand accounts with the medication, illustrating the drastic contrast between their pre and post #OzempicFace. The root of this problem is Semaglutide, which depletes the body and skin of vital nutrients and vitamins, while the drug's active ingredient targets collagen, elastin, and fat cells, causing volume loss and skin laxity issues.


While many believe dermal fillers to be the solution, they may not be the best option for regaining the volume, collagen, and elastin loss caused by Ozempic. Dermal fillers consist of Hyaluronic Acid (HA) which tends to attract water molecules. A more suitable option can be achieved with the use of Sculptra®, an injectable poly-L-lactic acid that stimulates the body's natural function to create more collagen. This gives the body the opportunity to naturally rebuild lost collagen and create a fuller appearance, leading to the overall improvement of what we now know to be #OzempicFace.

In addition, Sculptra® lasts much longer than dermal fillers, with studies showing the product can last more than two years, and based on clinical data, its lifespan was observed to be closer to three to five years. The administration of Sculptra is virtually painless and takes no more than an hour for a full facial treatment. Additionally, Sculptra is a great anti-aging treatment for achieving younger and healthier-looking skin. So if you're experiencing the effects of #OzempicFace, Sculptra might just be the solution you're looking for.

For more information, visit Amir Mortazavi, MD's social media: